CYTO logo

Altamira Therapeutics (CYTO) Company Overview

Profile

Full Name:

Altamira Therapeutics Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Bermuda

IPO:

August 6, 2014

Indexes:

Not included

Description:

CYTO, a part of Altamira Therapeutics, focuses on developing innovative therapies for various medical conditions. The company aims to improve patient outcomes through advanced drug delivery systems and targeted treatments, particularly in areas like respiratory diseases and neurological disorders.

Key Details

Price

$0.10

Annual Revenue

$188.40 K(-41.20% YoY)

Annual EPS

-$1.43(+99.77% YoY)

Annual ROE

1905.22%

Beta

-0.65

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Sep 8, 2021

Recent annual earnings:

Mar 31, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 13, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Altamira Therapeutics?
  • Does Altamira Therapeutics pay dividends?
  • What sector is Altamira Therapeutics in?
  • What industry is Altamira Therapeutics in?
  • What country is Altamira Therapeutics based in?
  • When did Altamira Therapeutics go public?
  • Is Altamira Therapeutics in the S&P 500?
  • Is Altamira Therapeutics in the NASDAQ 100?
  • Is Altamira Therapeutics in the Dow Jones?
  • When was Altamira Therapeutics's last earnings report?
  • When does Altamira Therapeutics report earnings?

What is the ticker symbol for Altamira Therapeutics?

The ticker symbol for Altamira Therapeutics is NASDAQ:CYTO

Does Altamira Therapeutics pay dividends?

No, Altamira Therapeutics does not pay dividends

What sector is Altamira Therapeutics in?

Altamira Therapeutics is in the Healthcare sector

What industry is Altamira Therapeutics in?

Altamira Therapeutics is in the Biotechnology industry

What country is Altamira Therapeutics based in?

Altamira Therapeutics is headquartered in Bermuda

When did Altamira Therapeutics go public?

Altamira Therapeutics's initial public offering (IPO) was on August 6, 2014

Is Altamira Therapeutics in the S&P 500?

No, Altamira Therapeutics is not included in the S&P 500 index

Is Altamira Therapeutics in the NASDAQ 100?

No, Altamira Therapeutics is not included in the NASDAQ 100 index

Is Altamira Therapeutics in the Dow Jones?

No, Altamira Therapeutics is not included in the Dow Jones index

When was Altamira Therapeutics's last earnings report?

Altamira Therapeutics's most recent earnings report was on Sep 8, 2021

When does Altamira Therapeutics report earnings?

The date for Altamira Therapeutics's next earnings report has not been announced yet